# DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

> **NCT03110159** · PHASE1,PHASE2 · COMPLETED · sponsor: **Medical Dermatology Specialists** · enrollment: 8 (actual)

## Conditions studied

- Skin Cancer
- Non-melanoma Skin Cancer
- Sun Damaged Skin
- Actinic Keratosis

## Interventions

- **DRUG:** Levulan® Kerastick®
- **DRUG:** BLU-U Blue Light Photodynamic Therapy

## Key facts

- **NCT ID:** NCT03110159
- **Lead sponsor:** Medical Dermatology Specialists
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-29
- **Primary completion:** 2024-02-20
- **Final completion:** 2024-02-20
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110159, "DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03110159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*